Donald G. Payan is EVP & Pres. Discovery&Research at RIGEL PHARMACEUTICALS INC (RIGL). They have made 4 open-market trades across 1 company since 2012, most recently 2016-08-30.
CIK 0001190275
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RIGL | 53,031 | $2.7M |
Shares reported on the most recent Form 4, priced at the 2016-09-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RIGL | SELL · 10b5-1 | 2016-08-30 | 2016-09-01 | $4.00 | $21K | -4.5% | +10.9% | -27.2% |
| RIGL | SELL | 2015-06-10 | 2015-06-12 | $3.68 | $153K | -8.6% | -5.6% | -5.6% |
| RIGL | SELL | 2015-04-01 | 2015-04-03 | $3.75 | $38K | -8.6% | -5.6% | -5.6% |
| RIGL | SELL | 2014-02-24 | 2014-02-26 | $3.71 | $74K | -8.6% | -5.6% | -5.6% |
| RIGL | SELL | 2012-06-19 | 2012-06-20 | $8.70 | $87K | -8.6% | -5.6% | -5.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.